Breaking News

Pernix to Divest Houston Manufacturing Ops

By Kristin Brooks | April 1, 2014

Woodfield to continue manufacturing existing Pernix products

Pernix Therapeutics Holdings, Inc. has signed a definitive agreement to divest its Houston, TX manufacturing operations, Pernix Manufacturing, LLC (PML), to Woodfield Pharmaceutical LLC. Woodfield will acquire the entire operation and will continue to manufacture the existing Pernix products under a long-term supply agreement. The transaction, excepted to close in the coming weeks, is subject to customary closing conditions.
Doug Drysdale, president and chief executive officer of Pernix said, “The sale of PML, along with the previously-announced closure of our distribution centers in Madison, MS and Magnolia, TX continues our efforts to reduce and simplify our operating costs. The transaction will be a significant contributor to profitability in 2014. We sincerely appreciate the contributions the PML team has made as part of the Pernix family and we look forward to working together with Woodfield to effect a smooth transition.”
Adam Runsdorf, president of Woodfield Pharmaceutical, LLC said, “We are pleased to participate in this transaction with Pernix and look forward to expanding the current platform of operations which will be dedicated to the service of existing and future customers requiring outsourced contract manufacturing.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks